Suchergebnisse - "Brufsky, Adam"

PubPharm (24)

1

Twenty-Year Follow-Up of a Phase II Trial of Taxotere/Carboplatin/Herceptin in Patients With Metastatic HER2-Positive Breast Cancer

enthalten in: The oncologist | 2023

von Gomez Marti, J. | Nasrazadani, A. | Ding, Y. | +2

2

Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41

enthalten in: Breast cancer research and treatment | 2023

von Rastogi, P. | Tang, G. | Hassan, S. | +16

3

Genetic Polymorphisms and Correlation with Treatment-Induced Cardiotoxicity and Prognosis in Patients with Breast Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Peddi, P. | Fasching, P. | Liu, D. | +17

4

Baseline characteristics and first-line treatment patterns in patients with HER2-positive metastatic breast cancer in the SystHERs registry

enthalten in: Breast cancer research and treatment | 2021

von Kaufman, P. | Hurvitz, S. | O'Shaughnessy, J. | +11

5

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA) : end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

enthalten in: The Lancet. Oncology | 2020

von Swain, S. | Miles, D. | Kim, S. | +113

CommentIn: Lancet Oncol. 2020 Apr;21(4):471-472. - PMID 32171427

6

De Novo Versus Recurrent HER2-Positive Metastatic Breast Cancer : Patient Characteristics, Treatment, and Survival from the SystHERs Registry

enthalten in: The oncologist | 2020

von Tripathy, D. | Brufsky, A. | Cobleigh, M. | +11

7

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer

enthalten in: The New England journal of medicine | 2020

von Modi, S. | Saura, C. | Yamashita, T. | +99

CommentIn: Cancer Discov. 2020 Feb;10(2):167. - PMID 31843763

8

Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology : A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2017

von Ganz, P. | Romond, E. | Cecchini, R. | +17

9

Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancer

enthalten in: Breast cancer research and treatment | 2014

von Yardley, D. | Kaufman, P. | Brufsky, A. | +6

10

Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41) : an open-label, randomised phase 3 trial

enthalten in: The Lancet. Oncology | 2013

von Robidoux, A. | Tang, G. | Rastogi, P. | +17

CommentIn: Lancet Oncol. 2013 Nov;14(12):1145-6. - PMID 24095298